Ethical and Policy Issues in Genetic Testing and Screening of Children

The genetic testing and genetic screening of children are commonplace. Decisions about whether to offer genetic testing and screening should be driven by the best interest of the child. The growing literature on the psychosocial and clinical effects of such testing and screening can help inform best practices. This policy statement represents recommendations developed collaboratively by the American Academy of Pediatrics and the American College of Medical Genetics and Genomics with respect to many of the scenarios in which genetic testing and screening can occur.

[1]  Jonathan S Berg,et al.  Points to Consider: Ethical, Legal, and Psychosocial Implications of Genetic Testing in Children and Adolescents. , 2015, American journal of human genetics.

[2]  H. Saal,et al.  Ethical and Policy Issues in Genetic Testing and Screening of Children , 2013, Pediatrics.

[3]  M. Treadwell,et al.  Screening U.S. college athletes for their sickle cell disease carrier status. , 2011, American journal of preventive medicine.

[4]  Rachel Grob.  Testing Baby: The Transformation of Newborn Screening, Parenting, and Policymaking , 2011 .

[5]  M. Kearney,et al.  Parents' Experiences of Expanded Newborn Screening Evaluations , 2011, Pediatrics.

[6]  K. Emmons,et al.  Parents' Attitudes Toward Pediatric Genetic Testing for Common Disease Risk , 2011, Pediatrics.

[7]  H. Frangoul,et al.  A parent's point of view on the American Academy of Pediatrics policy statement: Children as hematopoietic stem cell donors , 2011, Pediatric blood & cancer.

[8]  Caleb A. Greene.  Donor conception and children’s rights: a parent’s decision , 2011, Canadian Medical Association Journal.

[9]  A. Tluczek,et al.  Psychosocial Consequences of False-Positive Newborn Screens for Cystic Fibrosis , 2011, Qualitative health research.

[10]  R. Pollitt.  New technologies extend the scope of newborn blood‐spot screening, but old problems remain unresolved , 2010, Acta paediatrica.

[11]  Stefan Timmermans,et al.  Patients-in-Waiting , 2010, Journal of health and social behavior.

[12]  E. Neufeld,et al.  Primary care clinicians' knowledge and confidence about newborn screening for sickle cell disease: randomized assessment of educational strategies. , 2010, Journal of the National Medical Association.

[13]  L. Rohde,et al.  Pharmacogenetic approach for a better drug treatment in children. , 2010, Current pharmaceutical design.

[14]  J. Schiffman,et al.  Pharmacogenomics of pediatric acute lymphoblastic leukemia , 2010, Expert opinion on pharmacotherapy.

[15]  Timothy A. Geleske.  Weighing the evidence Recommendation made to add SCID to uniform newborn screening panel , 2010, AAP News.

[16]  C. McBride,et al.  Effects of genetic risk information on children's psychosocial wellbeing: A systematic review of the literature , 2010, Genetics in Medicine.

[17]  B. Wilcken.  Expanded newborn screening: reducing harm, assessing benefit , 2010, Journal of Inherited Metabolic Disease.

[18]  L. Ross.  Good Ethics Requires Good Science: Why Transplant Programs Should NOT Disclose Misattributed Parentage , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[19]  E. Bancroft.  Genetic testing for cancer predisposition and implications for nursing practice: narrative review. , 2010, Journal of advanced nursing.

[20]  C. Kieling,et al.  A current update on ADHD pharmacogenomics. , 2010, Pharmacogenomics.

[21]  S. Kardia,et al.  Understandings of Basic Genetics in the United States: Results from a National Survey of Black and White Men and Women , 2010, Public Health Genomics.

[22]  Sharon F Terry,et al.  Committee report: Method for evaluating conditions nominated for population-based screening of newborns and children , 2010, Genetics in Medicine.

[23]  L. Ross.  Children as Hematopoietic Stem Cell Donors , 2010, Pediatrics.

[24]  W. G. Feero,et al.  A blueprint for maternal and child health primary care physician education in medical genetics and genomic medicine: Recommendations of the United States Secretary for Health and Human Services Advisory Committee on Heritable Disorders in Newborns and Children , 2010, Genetics in Medicine.

[25]  G. Kutz.  Before the Subcommittee on Oversight and Investigations , Committee on Energy and Commerce , House of Representatives DIRECT-TO-CONSUMER GENETIC TESTS Misleading Test Results Are Further Complicated by Deceptive Marketing and Other Questionable Practices Statement of , 2010 .

[26]  S. Leonard,et al.  Childhood genetic testing for familial cancer: should adoption make a difference? , 2010, Familial Cancer.

[27]  R. Wheeler.  Predictive testing for pre-malignancy as a prelude to adoption? An English case , 2010, Familial Cancer.

[28]  D. Avard,et al.  Health-related direct-to-consumer genetic testing: a review of companies’ policies with regard to genetic testing in minors , 2010, Familial Cancer.

[29]  A. Lucassen,et al.  Family history and adoption in the UK: conflicts of interest in medical disclosure , 2009, Archives of Disease in Childhood.

[30]  Fiona Miller,et al.  Genetic education for primary care providers: improving attitudes, knowledge, and confidence. , 2009, Canadian family physician Medecin de famille canadien.

[31]  Roger L. Brown,et al.  Newborn Screening: An Appeal for Improved Parent Education , 2009, The Journal of perinatal & neonatal nursing.

[32]  Daniel Bonevac,et al.  A systematic review of literature about the genetic testing of adolescents. , 2009, Journal for specialists in pediatric nursing : JSPN.

[33]  S. Waisbren,et al.  Impact of false-positive newborn metabolic screening results on early health care utilization , 2009, Genetics in Medicine.

[34]  D. Postma,et al.  Pharmacogenetics of anti-inflammatory treatment in children with asthma: rationale and design of the PACMAN cohort. , 2009, Pharmacogenomics.

[35]  Terrill Bravender,et al.  Confidentiality, consent, and caring for the adolescent patient , 2009, Current opinion in pediatrics.

[36]  E. Ziv,et al.  Genetic ancestry modifies pharmacogenetic gene–gene interaction for asthma , 2009, Pharmacogenetics and genomics.

[37]  H. Tabor,et al.  Challenges in the Use of Direct-to-Consumer Personal Genome Testing in Children , 2009, The American journal of bioethics : AJOB.

[38]  Tao Wang,et al.  Social Networkers' Attitudes Toward Direct-to-Consumer Personal Genome Testing , 2009, The American journal of bioethics : AJOB.

[39]  Y. Amoateng-Adjepong,et al.  Complications associated with sickle cell trait: a brief narrative review. , 2009, The American journal of medicine.

[40]  R. Pollitt,et al.  Newborn blood spot screening: New opportunities, old problems , 2009, Journal of Inherited Metabolic Disease.

[41]  H. Northrup,et al.  Expanded newborn screening in Texas: a survey and educational module addressing the knowledge of pediatric residents , 2009, Genetics in Medicine.

[42]  W. Evans,et al.  Pharmacogenetics in acute lymphoblastic leukemia. , 2009, Seminars in hematology.

[43]  E. Chiu,et al.  Problems assessing uptake of Huntington disease predictive testing and a proposed solution , 2009, European Journal of Human Genetics.

[44]  Julia L. Sauer.  Competing interests and gamete donation: the case for anonymity. , 2009, Seton Hall law review.

[45]  E. Lose,et al.  The emerging role of primary care in genetics , 2008, Current opinion in pediatrics.

[46]  G. Koren,et al.  Pharmacogenetic insights into codeine analgesia: implications to pediatric codeine use. , 2008, Pharmacogenomics.

[47]  D. Levy,et al.  Differential use of available genetic tests among primary care physicians in the United States: results of a national survey , 2008, Genetics in Medicine.

[48]  C. Liao,et al.  Incidental Discovery of Nonpaternity during Prenatal Testing of Genetic Disease , 2008, Fetal Diagnosis and Therapy.

[49]  M. Levetown.  Communicating With Children and Families: From Everyday Interactions to Skill in Conveying Distressing Information , 2008, Pediatrics.

[50]  A. Andermann,et al.  Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years. , 2008, Bulletin of the World Health Organization.

[51]  J. Wardle,et al.  Associations between anticipated reactions to genetic test results and interest in genetic testing: will self-selection reduce the potential for harm? , 2008, Genetic testing.

[52]  P. Reynolds,et al.  Thinking ethically about genetic inheritance: liberal rights, communitarianism and the right to privacy for parents of donor insemination children , 2008, Journal of Medical Ethics.

[53]  A. Clarke,et al.  The micropolitics of responsibility vis-à-vis autonomy: parental accounts of childhood genetic testing and (non)disclosure. , 2008, Sociology of health & illness.

[54]  D. Paul.  Patient advocacy in newborn screening: Continuities and discontinuities , 2008, American journal of medical genetics. Part C, Seminars in medical genetics.

[55]  D. Hein,et al.  Clinical pharmacogenetics in pediatric patients. , 2007, Pharmacogenomics.

[56]  Gail Javitt,et al.  ASHG Statement* on Direct-to-Consumer Genetic Testing in the United States , 2007, Obstetrics and gynecology.

[57]  L. Kopelman.  Using the Best Interests Standard to decide whether to test children for untreatable, late-onset genetic diseases. , 2007, The Journal of medicine and philosophy.

[58]  J. Scully.  The Troubled Dream of Genetic Medicine: Ethnicity and Innovation in Tay-Sachs, Cystic Fibrosis, and Sickle Cell Disease , 2007 .

[59]  L. Johnson,et al.  Regulation of donor conception and the "time to tell" campaign. , 2007, Journal of law and medicine.

[60]  S. Barnoy.  Genetic testing for late-onset diseases: effect of disease controllability, test predictivity, and gender on the decision to take the test. , 2007, Genetic testing.

[61]  Marie Leiner,et al.  Communicating genetic information: a difficult challenge for future pediatricians , 2007, BMC medical education.

[62]  O. Lalos,et al.  Legislated right for donor-insemination children to know their genetic origin: a study of parental thinking. , 2007, Human reproduction.

[63]  L. Frith,et al.  UK gamete donors' reflections on the removal of anonymity: implications for recruitment. , 2007, Human reproduction.

[64]  K. Daniels.  Donor gametes: anonymous or identified? , 2007, Best practice & research. Clinical obstetrics & gynaecology.

[65]  L. Ross.  Heterozygote Carrier Testing in High Schools Abroad: What are the Lessons for the U.S.? , 2006, Journal of Law, Medicine & Ethics.

[66]  A. Kemper,et al.  Primary Care Physicians' Attitudes Regarding Follow-up Care for Children With Positive Newborn Screening Results , 2006, Pediatrics.

[67]  J. Cassiman,et al.  Presymptomatic and predictive genetic testing in minors: a systematic review of guidelines and position papers , 2006, Clinical genetics.

[68]  C. Kaye.  Newborn Screening Fact Sheets , 2006, Pediatrics.

[69]  Gideon Koren,et al.  Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother , 2006, The Lancet.

[70]  D. G. McCarver,et al.  Pharmacogenomics and the future of drug therapy. , 2006, Pediatric clinics of North America.

[71]  Dimitri A Christakis,et al.  State Newborn Screening in the Tandem Mass Spectrometry Era: More Tests, More False-Positive Results , 2006, Pediatrics.

[72]  S. Waisbren,et al.  Expanded Newborn Screening for Biochemical Disorders: The Effect of a False-Positive Result , 2006, Pediatrics.

[73]  S. Baumann.  Family Systems genetic Illness Model--breast cancer. , 2006, Clinical journal of oncology nursing.

[74]  Penny Kyler,et al.  Recommendations for Effective Newborn Screening Communication: Results of Focus Groups With Parents, Providers, and Experts , 2006, Pediatrics.

[75]  Ellen Wright Clayton,et al.  Newborn Screening Technology: Proceed With Caution , 2006, Pediatrics.

[76]  T. Tonniges,et al.  American Academy of Pediatrics Newborn Screening Task Force Recommendations: How Far Have We Come? , 2006, Pediatrics.

[77]  W. Mayr,et al.  Mother–child exclusion due to paternal uniparental disomy 6 , 2006, International Journal of Legal Medicine.

[78]  M. Khoury,et al.  From Public Health Emergency to Public Health Service: The Implications of Evolving Criteria for Newborn Screening Panels , 2006, Pediatrics.

[79]  A. Newson.  Should Parental Refusals of Newborn Screening Be Respected? , 2006, Cambridge Quarterly of Healthcare Ethics.

[80]  J. L. Haidle,et al.  Legal considerations in clinical cancer genetics , 2006 .

[81]  S. Peterson.  The Role of the Family in Genetic Testing: Theoretical Perspectives, Current Knowledge, and Future Directions , 2005, Health education & behavior : the official publication of the Society for Public Health Education.

[82]  M. Natowicz.  Newborn screening--setting evidence-based policy for protection. , 2005, The New England journal of medicine.

[83]  R. Eeles,et al.  Men’s Decision-Making About Predictive BRCA1/2 Testing: The Role of Family , 2005, Journal of Genetic Counseling.

[84]  A. Clarke,et al.  Genetic professionals' reports of nondisclosure of genetic risk information within families , 2005, European Journal of Human Genetics.

[85]  J. Tillett.  Adolescents and informed consent: ethical and legal issues. , 2005, The Journal of perinatal & neonatal nursing.

[86]  M. Van Riper.  Genetic testing and the family. , 2005, Journal of midwifery & women's health.

[87]  M. Fabrizio,et al.  Misattributed paternity in a living related donor: to disclose or not to disclose? , 2004, Urology.

[88]  P. Hagerman,et al.  The fragile-X premutation: a maturing perspective. , 2004, American journal of human genetics.

[89]  L. Ross,et al.  Incorporating newborn screening into prenatal care. , 2004, American journal of obstetrics and gynecology.

[90]  D. Borchers.  Families and adoption: the pediatrician's role in supporting communication. , 2003, Pediatrics.

[91]  Edwin W. Naylor,et al.  Effect of Expanded Newborn Screening for Biochemical Genetic Disorders on Child Outcomes and Parental Stress , 2003 .

[92]  R. Listernick.  A 30-month-old boy with developmental regression and hepatosplenomegaly. , 2003, Pediatric annals.

[93]  L. Ross,et al.  Parental attitudes regarding newborn screening of PKU and DMD , 2003, American journal of medical genetics. Part A.

[94]  B. Fernandez,et al.  Predictive, pre‐natal and diagnostic genetic testing for Huntington's disease: the experience in Canada from 1987 to 2000 , 2003, Clinical genetics.

[95]  R. Howard,et al.  Pharmacogenetics of codeine metabolism in an urban population of children and its implications for analgesic reliability. , 2002, British journal of anaesthesia.

[96]  T. Savitt.  Dying in the city of the blues: sickle cell anemia and the politics of race and health , 2002, Medical History.

[97]  L. Ross.  Predictive Genetic Testing for Conditions that Present in Childhood , 2002, Kennedy Institute of Ethics journal.

[98]  S. Abbey,et al.  Disclosure of Misattributed Paternity: Issues Involved in the Discovery of Unsought Information , 2002, Seminars in dialysis.

[99]  M. Dumont-Driscoll.  Genetics and the general pediatrician: where do we belong in this exploding field of medicine? , 2002, Current problems in pediatric and adolescent health care.

[100]  B. Wilfond,et al.  Ethical issues with genetic testing in pediatrics. , 2013, Pediatrics.

[101]  L. Ross,et al.  The ethics of preadoption genetic testing. , 2001, American journal of medical genetics.

[102]  L. Wissow,et al.  Disclosure of HIV diagnosis to children: when, where, why, and how. , 2001, Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners.

[103]  H. Hoyme,et al.  Molecular genetic testing in pediatric practice: A subject review. Committee on Genetics. , 2016, Pediatrics.

[104]  B. Meiser,et al.  Psychological impact of genetic testing for Huntington's disease: an update of the literature , 2000, Journal of neurology, neurosurgery, and psychiatry.

[105]  Illinois.,et al.  Serving the family from birth to the medical home. Newborn screening: a blueprint for the future - a call for a national agenda on state newborn screening programs , 2000, Pediatrics.

[106]  M. Rothstein,et al.  Genetic testing in adoption. The American Society of Human Genetics Social Issues Committee and The American College of Medical Genetics Social, Ethical, and Legal Issues Committee. , 2000, American journal of human genetics.

[107]  George M. Anderson,et al.  Pharmacogenetics. Promise and potential in child and adolescent psychiatry. , 2000, Child and adolescent psychiatric clinics of North America.

[108]  L. Ross.  Children, Families, and Health Care Decision Making , 1999 .

[109]  M. Freundlich.  The case against preadoption genetic testing. , 1998, Child welfare.

[110]  E. Clayton.  What should the law say about disclosure of genetic information to relatives? , 1998, Journal of health care law & policy.

[111]  L B Andrews,et al.  Adoption, reproductive technologies, and genetic information. , 1998, Health matrix.

[112]  S. di Somma,et al.  Development of cardiomyopathy in female carriers of Duchenne and Becker muscular dystrophies. , 1996, JAMA.

[113]  W. Bartholome.  Informed consent, parental permission, and assent in pediatric practice. , 1995, Pediatrics.

[114]  A. Clarke.  The genetic testing of children. , 1995, Journal of medical genetics.

[115]  A. Clarke,et al.  The genetic testing of children. Working Party of the Clinical Genetics Society (UK) , 1994, Journal of medical genetics.

[116]  J. La Puma,et al.  Disclosure of a diagnosis to children and adolescents when parents object. A clinical ethics analysis. , 1993, American journal of diseases of children.

[117]  N. Holtzman,et al.  Primary care physicians as providers of frontline genetic services. , 1993, Fetal diagnosis and therapy.

[118]  E. Clayton.  Screening and treatment of newborns. , 1992, Houston law review.

[119]  Bruce L. Miller,et al.  Office of Technology Assessment Task Force , 1991 .

[120]  O. Barbarin,et al.  Does "telling" less protect more? Relationships among age, information disclosure, and what children with cancer see and feel. , 1991, Journal of pediatric psychology.

[121]  L. Forrow,et al.  Deciding for others: The ethics of surrogate decision‐making , 1990 .

[122]  R. Walker,et al.  Paternity testing with an absent mother. The probability of exclusion of red cell surface antigen, Gm, Hp, and HLA systems in North American whites and blacks. , 1989, Transfusion.

[123]  N. Holtzman,et al.  A survey to evaluate parental consent as public policy for neonatal screening. , 1982, American journal of public health.

[124]  Leikin Sl.  An ethical issue in pediatric cancer care: nondisclosure of a fatal prognosis. , 1981 .

[125]  S. Leikin.  An ethical issue in pediatric cancer care: nondisclosure of a fatal prognosis. , 1981, Pediatric annals.

[126]  J. Tjio,et al.  The chromosome number of man. , 1978, American journal of obstetrics and gynecology.

[127]  F. Crick,et al.  Molecular Structure of Nucleic Acids: A Structure for Deoxyribose Nucleic Acid , 1974, Nature.

[128]  Ja Wilson,et al.  Principles and practice of screening for disease , 1968 .